Results 241 to 250 of about 20,678 (258)

MEDICAL USE OF A DPP-4 INHIBITOR

2015
KLEIN THOMAS, ADVANI ANDREW, CONNELLY KIM ALEXANDER, GILBERT RICHARD ERNEST   +3 more
openaire   +3 more sources

Long-acting peptidomimetics based DPP-IV inhibitors

Bioorganic and Medicinal Chemistry Letters, 2012
Mukul Jain, Amit Joharapurkar, Shailesh Shāh   +2 more
exaly  

Design, Synthesis, and in Vitro Evaluation of Novel Aminomethyl-pyridines as DPP-4 Inhibitors

ACS Medicinal Chemistry Letters, 2010
Katarzyna Kaczanowska, Karl-Heinz Wiesmüller   +1 more
exaly  

Glucagon-Like Receptor 1 Agonists and DPP-4 Inhibitors: Potential Therapies for the Treatment of Stroke

Journal of Cerebral Blood Flow and Metabolism, 2015
Martin Larsson, Thomas Nyström, David Nathanson   +2 more
exaly  

Trough DPP-4 Inhibition Differs between the Approved DPP-4 Inhibitors

MD Conference Express, 2013
openaire   +1 more source

Future perspectives for insulinotropic agents in the treatment of type 2 diabetes–DPP‐4 inhibitors and sulphonylureas

Diabetes, Obesity and Metabolism, 2010
Baptist Gallwitz, H‐U Haring
exaly  

Choosing a DPP-4 Inhibitor

2013
openaire   +1 more source

DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics

Heart Failure Reviews, 2017
Chayakrit Krittanawong, Marrick Kukin, Andrew Xanthopoulos   +2 more
exaly  

Synthetic Approaches to Novel DPP-IV Inhibitors—A Literature Review

Molecules
Aleksandar Pashev
exaly  

DPP-4 Inhibitors: Combination Therapy

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source